Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Fecal bacteria

ABSTRACT: Fecal bacteria Genome sequencing and assembly

PROVIDER: PRJNA874082 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21230207_1.fastq.gz	Fastqsanger.gz
	SRR21230207_2.fastq.gz	Fastqsanger.gz
	SRR21230208_1.fastq.gz	Fastqsanger.gz
	SRR21230208_2.fastq.gz	Fastqsanger.gz
	SRR21230209_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 20

Similar Datasets

The composition of the bacteria found in liver, spleen, oral cavity and fecal samples of mice subjected to an experimental periodontitis model

Project description:Periodontitis patients often develop bacteremia, but there has been little evidence showing that oral bacteria translocate into other organs. We found that bacterial colony formation occurs in a culture of liver and spleen cells of periodontitis-induced mice, and the bacterial species detected in the liver and spleen were found in the oral cavity as well, but not in fecal samples, indicating systemic dissemination of oral bacteria during the breakdown of the oral barrier.

2018-01-26 | GSE109664 | GEO

Metagenome of pig fecal bacteria

Project description:Metagenome of pig fecal bacteria Metagenome

| PRJNA722155 | ENA

fecal bacteria of Holstein steer

Project description:fecal bacteria of Holstein steer Raw sequence reads

| PRJNA534207 | ENA

fecal bacteria of Holstein steer

Project description:fecal bacteria of Holstein steer Raw sequence reads

| PRJNA560144 | ENA

feces metagenome strain:Bacteria | isolate:Fecal bacteria | breed:Thoroughbred

Project description:feces metagenome strain:Bacteria | isolate:Fecal bacteria | breed:Thoroughbred Metagenome

| PRJNA326194 | ENA

fecal

Project description:fecal Genome sequencing and assembly

| PRJNA613970 | ENA

Effect of fecal bacteria transplantation on immunotherapy for advanced colorectal cancer: A single-center, prospective, randomized controlled study

Project description:Interventions: experimental group:Fecal bacteria transplantation + immunotherapy;control group:Immunotherapy only Primary outcome(s): Objective response rate;Progression-free survival;Overall survival Study Design: Parallel

| 2741229 | ecrin-mdr-crc

Fecal microbial infusion from lean donors increases insulin sensitivity in subjects with metabolic syndrome

Project description:Alterations in intestinal microbiota and intestinal short chain fatty acids profiles have been associated with the pathophysiology of obesity and insulin resistance. Whether intestinal microbiota dysbiosis is a causative factor in humans remains to be clarified We examined the effect of fecal microbial infusion from lean donors on the intestinal microbiota composition, glucose metabolism and small intestinal gene expression. Male subjects with metabolic syndrome underwent bowel lavage and were randomised to allogenic (from male lean donors with BMI<23 kg/m2, n=9) or autologous (reinfusion of own feces, n=9) fecal microbial transplant. Insulin sensitivity and fecal short chain fatty acid harvest were measured at baseline and 6 weeks after infusion. Intestinal microbiota composition was determined in fecal samples and jejunal mucosal biopsies were also analyzed for the host transcriptional response. Insulin sensitivity significantly improved six weeks after allogenic fecal microbial infusion (median Rd: from 26.2 to 45.3 μmol/kg.min, p<0.05). Allogenic fecal microbial infusion increased the overall amount of intestinal butyrate producing microbiota and enhanced fecal harvest of butyrate. Moreover, the transcriptome analysis of jejunal mucosal samples revealed an increased expression of genes involved in a G-protein receptor signalling cascade and subsequently in glucose homeostasis. Lean donor microbial infusion improves insulin sensitivity and levels of butyrate-producing and other intestinal microbiota in subjects with the metabolic syndrome. We propose a model wherein these bacteria provide an attractive therapeutic target for insulin resistance in humans. (Netherlands Trial Register NTR1776).

2020-10-28 | GSE30854 | GEO

Fecal filtrate transfer protects against necrotizing enterocolitis in preterm pigs

Project description:Necrotizing enterocolitis (NEC) is an acute and life-threatening gastrointestinal disorder afflicting preterm infants, which is currently unpreventable. Fecal microbiota transplantation (FMT) is a promising preventative therapy, but potential bacterial infection raise concern. Removal of bacteria from donor feces may reduce this risk while maintaining the NEC-preventive effects. We aimed to assess preclinical efficacy and safety of bacteria-free fecal filtrate transfer (FFT). Using fecal material from healthy suckling piglets, we administered FMT rectally, or cognate FFT either rectally or oro-gastrically to formula-fed preterm, cesarean-delivered piglets as a model for preterm infants, We compared gut pathology and related safety parameters with saline controls, and analyzed ileal mucosal transcriptome to gauge the host e response to FMT and FFT treatments relative to control. Results showed that oro-gastric FFT prevented NEC, whereas FMT did not perform better than control. Moreover, FFT but not FMT reduced intestinal permeability, whereas FMT animals had reduced body weight increase and intestinal growth. Global gene expression of host mucosa responded to FMT but not FFT with increased and decreased bacterial and viral defense mechanisms, respectively. In conclusion, as preterm infants are extremely vulnerable to enteric bacterial infections, rational NEC-preventive strategies need incontestable safety profiles. Here we show in a clinically relevant animal model that FFT, as opposed to FMT, efficiently prevents NEC without any recognizable side effects. If translatable to preterm infants, this could lead to a change of practice and in turn a reduction in NEC burden.

2021-10-01 | GSE158878 | GEO

fecal sample

Project description:fecal sample Genome sequencing and assembly

| PRJNA1089835 | ENA